On October 30, 2020 Hutchison China MediTech Limited ("Chi-Med") (Nasdaq/AIM: HCM) reported that Mr. Christian Hogg, Chief Executive Officer of Chi-Med, will present or participate in the following virtual conferences (Press release, Hutchison China MediTech, OCT 30, 2020, https://www.chi-med.com/chi-med-to-attend-upcoming-industry-and-investor-virtual-conferences/ [SID1234569517]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 15th Citi China Investor Conference on Thursday, November 5, 2020; and
The "China Summit Survey Results: Where is the "Bridge to Innovation" Headed?" Panel as part of the BioCentury-BayHelix 7th China Healthcare Summit on Monday, November 9, 2020.
Members of the management team will attend the above conferences in one-on-one meetings, and will also attend the following virtual investor conferences at certain times:

The Bank of America 2020 China Conference held from November 2 to 13, 2020;
The Goldman Sachs Asia Pacific Healthcare Forum held from November 16 to 18, 2020;
The 11th Annual Jefferies Global Healthcare Conference held from November 17 to 19, 2020;
The Morgan Stanley Asia Pacific Summit held from November 18 to 20, 2020; and
The Piper Sandler 32nd Annual Healthcare Conference held from December 1 to 3, 2020.
Further information are available at www.chi-med.com in the Shareholder Information section under "Events, Circulars & Forms."